The new consortium partners expand CSDR's ability to help accelerate life-saving discoveries and efficiently translate big data into smart data that generates valuable research results.
With the addition of non-profit partners, CSDR is uniquely positioned to not only serve the research community through access to patient-level clinical data from the pharmaceutical industry, but also as a resource through which academic-led clinical trial data now can be shared.
ClinicalStudyDataRequest.com is an online resource giving researchers access to patient-level clinical trial data from 14 pharmaceutical companies across multiple therapeutic areas.
Its multi-sponsor request system provides a secure process for researchers to request access to global clinical trial data through a publicly available website.
An independent review panel reviews data requests received from external researchers. Wellcome Trust provides secretarial support to this panel and oversees the review process.
Diamyd Medical agrees accelerated efficacy readout in ongoing Phase 3 type 1 diabetes trial
INOVIO's INO-3107 Biologics License Application accepted by US FDA
ABL Bio receives upfront payment and equity investment from Eli Lilly
CARsgen Therapeutics submits two IND applications for CT0596 to Chinese regulator
Repare Therapeutics sells RP-3467 asset to Gilead Sciences for up to USD30m
Sanofi agrees USD2.2bn acquisition of Dynavax to strengthen adult vaccine portfolio
Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11
Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA
NeuroSense Therapeutics completes safety evaluation of PrimeC in Alzheimer's Phase 2 study
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Faron launches BLAZE trial with Institute of Cancer Research to address immunotherapy resistance
AstraZeneca secures US Breakthrough status for Enhertu in early breast cancer
Ipsen licenses Simcere Zaiming antibody-drug conjugate for global development